TNI medical AG develops, produces and sells devices for respiratory therapy used in intensive clinical, inpatient and home care settings. The company recently introduced the TNI®softFlow system, which the article says maximizes patient comfort while providing full respiratory support. Its devices are used to treat adult conditions such as COPD and ILD, as well as neonatal and pediatric conditions including IRDS, BPD, bronchiolitis and mild to moderate obstructive sleep apnea syndrome. The company is led by CEO Ewald Anger and is based in Würzburg, Germany. Financially, TNI medical raised €3m in venture capital funding in the disclosed transaction. The investment was made by Pathena Fund.

Total raised

$3M

Funding rounds

1

Latest round

Equity

Latest activity

Oct 2015